Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Difference in redness of Ultraviolet B induced erythema with 4% imipramine
Timeframe: 10 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% imipramine
Timeframe: 60 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% imipramine
Timeframe: 120 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% imipramine
Timeframe: 24 hours post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% amitriptyline
Timeframe: 10 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% amitriptyline
Timeframe: 60 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% amitriptyline
Timeframe: 120 minutes post-treatment
Difference in redness of Ultraviolet B induced erythema with 4% amitriptyline
Manager Clinical Research Operations
Timeframe: 24 hours post-treatment